26.04.2019 • NewsCatalentDede Willams

Catalent Expands German Softgel Output

Catalent Expands German Softgel Output
Catalent Expands German Softgel Output

US drug developer Catalent has announced plans to expand its integrated turnkey softgel capabilities at Eberbach, Germany, at a cost of $14 million up to 2020. The expansion includes two new encapsulation lines using the company’s proprietary Vegicaps technology.

Catalent said the expansion is being driven in particular by increased global demand for animal-free consumer health products. Expanded facilities for these products are planned to be in the market by September 2019.  The investment also includes new printing technology, a state-of-the-art vision inspection system, expansion of softgel coating capabilities and additional packaging capacity.

The Eberbach site, Catalent’s biggest softgel development and manufacturing facility in Europe with a capacity of more than 10 billion capsules per year, is also adding 10% to the workforce  across operations, quality control and related support functions.

Raoul Bernhardt, general manager of the site, said the investment reflects the importance of Eberbach and will enable the company to provide its customers with increased volumes and turnkey services.

Expanded several times – the last time in 2015 – the German facility offers integrated softgel manufacturing services, which the CMDO said simplify supply chain management and deliver products faster to market. 

Along with prescription and OTC drugs, nutritional supplements, medical devices and animal health products, Eberbach also handles highly potent and cytotoxic compounds within an isolated, self-contained cytotoxic suite, Catalent said.

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

Virtual Event

Digitalization in the Chemical Industry
CHEManager Spotlight

Digitalization in the Chemical Industry

Save the Date: October 22, 2025
The event will be promoted to a combined audience of over 100,000 professionals across Europe through the CHEManager and CITplus networks.

most read

Photo
22.04.2025 • News

BASF Divests Two Joint Ventures in China

BASF has divested its shares in the joint venture companies, BASF Markor Chemical Manufacturing (Xinjiang) Co., Ltd. and Markor Meiou Chemical (Xinjiang) Co., Ltd. in Korla, China, to Verde Chemical Singapore Pte. Ltd.

Photo
19.03.2025 • News

Arkema Launches Acrylic Acid Purification Project

Arkema has announced the launch of its Carat Project at its Carling site in France. This initiative aims to enhance the capabilities and sustainability of the facility, which specializes in producing acrylic monomers and superabsorbent polymers.

Photo
13.03.2025 • News

Roche and Zealand Pharma Collaborate on Weight Management Drug

Swiss pharma heavyweight Roche announced has entered into an exclusive collaboration and licensing agreement with Denmark’s Zealand Pharma. Under the terms of this agreement, the two companies will collaborate to co-develop and co-commercialize petrelintide, Zealand Pharma’s amylin analog as a standalone therapy as well as a fixed-dose combination with Roche’s lead incretin asset CT-388.